We are thrilled to announce that Picodya is a winner of The Genesis Prize and Start-Up Nation Central’s joint competition, recognizing outstanding technological innovations developed by Israeli companies to fight the Covid-19 pandemic. This unique competition, initiated by 2020 Genesis Prize Laureate Natan Sharansky in cooperation with the Genesis Prize Foundation and Start-Up Nation Central, recognizes leading Israeli companies working to combat coronavirus and the damage of future pandemics. Picodya was selected by a distinguished judging panel in the “Diagnostics & Decision Support” category for its IVD platform suitable for point-of-care deployment, which will be invaluable during this and other healthcare crises.
We are honored to be recognized for our contribution to the global battle against COVID-19 as well as wider diagnostic access around the globe.
